Recombinant Human NGAL/Lipocalin-2 Protein (His Tag, Human Cells)
SKU: PKSH032806-50
Recombinant Human NGAL/Lipocalin-2 Protein (His Tag, Human Cells)
SKU # | PKSH032806 |
Expression Host | HEK293 Cells |
Description
Synonyms | 25 kDa alpha-2-microglobulin-related subunit of MMP-9, HNL, Lipocalin-2, NGAL, Neutrophil gelatinase-associated lipocalin, Oncogene 24p3, Siderocalin LCN2, p25 |
Species | Human |
Expression Host | HEK293 Cells |
Sequence | Gln21-Gly198 |
Accession | P80188 |
Calculated Molecular Weight | 21.6 kDa |
Observed Molecular Weight | 23 kDa |
Tag | C-His |
Bio-activity | Not validated for activity |
Properties
Purity | > 95 % as determined by reducing SDS-PAGE. |
Endotoxin | < 1.0 EU per μg of the protein as determined by the LAL method. |
Storage | Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles. |
Shipping | This product is provided as liquid. It is shipped at frozen temperature with blue ice/gel packs. Upon receipt, store it immediately at < - 20°C. |
Formulation | Supplied as a 0.2 μm filtered solution of PBS, 50% Glycerol, pH 7.4. |
Reconstitution | Not Applicable |
Background
LCN2 is iron-trafficking protein involved in multiple processes such as apoptosis; innate immunity and renal development. LCN2 binds iron through association with 2;5-dihydroxybenzoic acid (2;5-DHBA); a siderophore that shares structural similarities with bacterial enterobactin; and delivers or removes iron from the cell; depending on the context. LCN2 is involved in apoptosis due to interleukin-3 (IL3) deprivation: iron-loaded form increases intracellular iron concentration without promoting apoptosis; while iron-free form decreases intracellular iron levels; inducing expression of the proapoptotic protein BCL2L11/BIM; resulting in apoptosis. LCN2 is involved in innate immunity; possibly by sequestrating iron; leading to limit bacterial growth.